Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Exploration of Non-Invasive Diagnostic Strategies for Prostate Cancer (PCa) and Benign Prostatic Hyperplasia (BPH) Based on Body Fluid miRNA Panels: A Prospective Diagnostic Study

NCT07755592 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07755592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07755592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Exploration of Non-Invasive Diagnostic Strategies for Prostate Cancer (PCa) and Benign Prostatic Hyperplasia (BPH) Based on Body Fluid miRNA Panels: A Prospective Diagnostic Study
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 13, 2026
Completion date
December 1, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer (diagnosis)